Log In
Print
BCIQ
Print
Print this Print this
 

CCX168

Also known as: C5aR inhibitor

  Manage Alerts
Collapse Summary General Information
Company ChemoCentryx Inc.
DescriptionSmall molecule complement receptor 5a (C5aR; CD88) inhibitor
Molecular Target Complement receptor 5a (CD88)
Mechanism of ActionComplement receptor 5a inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard Indication Inflammation (unspecified)
Indication DetailsTreat antineutrophil cytoplasmic antibody (ANCA)-associated renal vasculitis; Treat antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis
Regulatory Designation

U.S. - Orphan Drug (Treat antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis)

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today